173 related articles for article (PubMed ID: 27889994)
1. PD-1/PD-Ls: A New Target for Regulating Immunopathogenesis in Central Nervous System Disorders.
Wu J; Yu Z; Chen G
Curr Drug Deliv; 2017 Sep; 14(6):791-796. PubMed ID: 27889994
[TBL] [Abstract][Full Text] [Related]
2. The roles of the PD-1/PD-L1 pathway at immunologically privileged sites.
Wang LL; Li ZH; Hu XH; Muyayalo KP; Zhang YH; Liao AH
Am J Reprod Immunol; 2017 Aug; 78(2):. PubMed ID: 28585775
[TBL] [Abstract][Full Text] [Related]
3. The PD-1/PD-Ls pathway and autoimmune diseases.
Dai S; Jia R; Zhang X; Fang Q; Huang L
Cell Immunol; 2014 Jul; 290(1):72-9. PubMed ID: 24908630
[TBL] [Abstract][Full Text] [Related]
4. Emerging Role of PD-1 in the Central Nervous System and Brain Diseases.
Zhao J; Roberts A; Wang Z; Savage J; Ji RR
Neurosci Bull; 2021 Aug; 37(8):1188-1202. PubMed ID: 33877518
[TBL] [Abstract][Full Text] [Related]
5. PD-1/PD-Ls pathways between CD4(+) T cells and pleural mesothelial cells in human tuberculous pleurisy.
Yin W; Tong ZH; Cui A; Zhang JC; Ye ZJ; Yuan ML; Zhou Q; Shi HZ
Tuberculosis (Edinb); 2014 Mar; 94(2):131-9. PubMed ID: 24406080
[TBL] [Abstract][Full Text] [Related]
6. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.
Lehnardt S
Glia; 2010 Feb; 58(3):253-63. PubMed ID: 19705460
[TBL] [Abstract][Full Text] [Related]
7. Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis.
Alvarez IB; Pasquinelli V; Jurado JO; Abbate E; Musella RM; de la Barrera SS; García VE
J Infect Dis; 2010 Aug; 202(4):524-32. PubMed ID: 20617899
[TBL] [Abstract][Full Text] [Related]
8. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.
Sharpe AH; Wherry EJ; Ahmed R; Freeman GJ
Nat Immunol; 2007 Mar; 8(3):239-45. PubMed ID: 17304234
[TBL] [Abstract][Full Text] [Related]
9. PD-1 and its ligands are important immune checkpoints in cancer.
Dong Y; Sun Q; Zhang X
Oncotarget; 2017 Jan; 8(2):2171-2186. PubMed ID: 27974689
[TBL] [Abstract][Full Text] [Related]
10. Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis.
Birtas Atesoglu E; Tarkun P; Demirsoy ET; Geduk A; Mehtap O; Batman A; Kaya F; Cekmen MB; Gulbas Z; Hacıhanefioglu A
Clin Appl Thromb Hemost; 2016 Apr; 22(3):248-51. PubMed ID: 25510412
[TBL] [Abstract][Full Text] [Related]
11. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.
Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR
Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977
[TBL] [Abstract][Full Text] [Related]
12. PD-1 is a novel regulator of human B-cell activation.
Thibult ML; Mamessier E; Gertner-Dardenne J; Pastor S; Just-Landi S; Xerri L; Chetaille B; Olive D
Int Immunol; 2013 Feb; 25(2):129-37. PubMed ID: 23087177
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for detection of invading pathogens in the brain.
Falsig J; van Beek J; Hermann C; Leist M
J Neurosci Res; 2008 May; 86(7):1434-47. PubMed ID: 18061944
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Immunosuppressive Molecules, PD-1 and PD-L1 but not PD-L2, in the Patients with Multiple Sclerosis.
Javan MR; Aslani S; Zamani MR; Rostamnejad J; Asadi M; Farhoodi M; Nicknam MH
Iran J Allergy Asthma Immunol; 2016 Aug; 15(4):296-302. PubMed ID: 27921410
[TBL] [Abstract][Full Text] [Related]
15. The role of IL-15 in central nervous system disorders.
Rentzos M; Rombos A
Acta Neurol Scand; 2012 Feb; 125(2):77-82. PubMed ID: 21615353
[TBL] [Abstract][Full Text] [Related]
16. Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα.
Nuro-Gyina PK; Rieser EL; Granitto MC; Pei W; Liu Y; Lee PW; Aqel S; Zhang J; Lovett-Racke AE; Racke MK; Yang Y
J Neuroinflammation; 2016 Dec; 13(1):302. PubMed ID: 27912762
[TBL] [Abstract][Full Text] [Related]
17. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
18. Brain-immune connection: immuno-regulatory properties of CNS-resident cells.
Becher B; Prat A; Antel JP
Glia; 2000 Feb; 29(4):293-304. PubMed ID: 10652440
[TBL] [Abstract][Full Text] [Related]
19. The role of IL-17 in CNS diseases.
Waisman A; Hauptmann J; Regen T
Acta Neuropathol; 2015 May; 129(5):625-37. PubMed ID: 25716179
[TBL] [Abstract][Full Text] [Related]
20. Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis.
Duchnowska R; Pęksa R; Radecka B; Mandat T; Trojanowski T; Jarosz B; Czartoryska-Arłukowicz B; Olszewski WP; Och W; Kalinka-Warzocha E; Kozłowski W; Kowalczyk A; Loi S; Biernat W; Jassem J;
Breast Cancer Res; 2016 Apr; 18(1):43. PubMed ID: 27117582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
